Blood clearance rates of adenovirus type 5 in mice

被引:336
作者
Alemany, R [1 ]
Suzuki, K [1 ]
Curiel, DT [1 ]
机构
[1] Univ Alabama, Div Human Gene Therapy, Wallace Tumor Inst, Birmingham, AL 35294 USA
关键词
D O I
10.1099/0022-1317-81-11-2605
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Persistence of adenovirus type 5 in blood has implications for the pathogenicity of the virus infection and for the use of this virus in oncolysis and gene therapy. In this study, the kinetics of adenovirus clearance from blood in mice has been evaluated. After a single inoculation of concentrated virus into the vena cava, virus half-life was less than 2 min. Depletion of Kupffer cells (KC) resulted in increased viraemia. After tail-vein injection, virus and latex beads co-localized within KIC. An important factor in clearance by KC is the negative charge of particles. Deletion of the hexon hypervariable region 1 acidic stretch decreased the negative charge of the virion but it did not increase blood persistence. Coating with PEG ('PEGylation') reduced the clearance rate but also reduced infectivity.
引用
收藏
页码:2605 / 2609
页数:5
相关论文
共 25 条
  • [1] Alemany R, 1996, CANCER GENE THER, V3, P296
  • [2] PEG-COATED POLY(LACTIC ACID) NANOPARTICLES FOR THE DELIVERY OF HEXADECAFLUORO ZINC PHTHALOCYANINE TO EMT-6 MOUSE MAMMARY-TUMORS
    ALLEMANN, E
    BRASSEUR, N
    BENREZZAK, O
    ROUSSEAU, J
    KUDREVICH, SV
    BOYLE, RW
    LEROUX, JC
    GURNY, R
    VANLIER, JE
    [J]. JOURNAL OF PHARMACY AND PHARMACOLOGY, 1995, 47 (05) : 382 - 387
  • [3] BRUNNER KT, 1960, J IMMUNOL, V85, P99
  • [4] Efficient generation of recombinant adenovirus vectors by homologous recombination in Escherichia coli
    Chartier, C
    Degryse, E
    Gantzer, M
    Dieterle, A
    Pavirani, A
    Mehtali, M
    [J]. JOURNAL OF VIROLOGY, 1996, 70 (07) : 4805 - 4810
  • [5] Adenovirus complexed with polyethylene glycol and cationic lipid is shielded from neutralizing antibodies in vitro
    Chillon, M
    Lee, JH
    Fasbender, A
    Welsh, MJ
    [J]. GENE THERAPY, 1998, 5 (07) : 995 - 1002
  • [6] Analysis of 15 adenovirus hexon proteins reveals the location and structure of seven hypervariable regions containing serotype-specific residues
    CrawfordMiksza, L
    Schnurr, DP
    [J]. JOURNAL OF VIROLOGY, 1996, 70 (03) : 1836 - 1844
  • [7] Davern TJ, 1999, HEPATOLOGY, V30, p490A
  • [8] Expression of Coxsackie adenovirus receptor and alphav-integrin does not correlate with adenovector targeting in vivo indicating anatomical vector barriers
    Fechner, H
    Haack, A
    Wang, H
    Wang, X
    Eizema, K
    Pauschinger, M
    Schoemaker, RG
    van Veghel, R
    Houtsmuller, AB
    Schultheiss, HP
    Lamers, JMJ
    Poller, W
    [J]. GENE THERAPY, 1999, 6 (09) : 1520 - 1535
  • [9] GABIZON A, 1994, CANCER RES, V54, P987
  • [10] FURTHER SUBGROUPING OF HUMAN ADENOVIRUSES BY DIFFERENTIAL HEMAGGLUTINATION
    HIERHOLZER, JC
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1973, 128 (04) : 541 - 550